{"nct_id":"NCT03829657","title":"Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","status":"TERMINATED","status_verified_date":"2022-12","start_date":"2019-02-22","start_date_type":"ACTUAL","primary_completion_date":"2021-11-10","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TBPH"]}